National Commission on Correctional Health Care Position Statement

Bader, T. F. (1986). Hepatitis B in prison. Biomedicine and Pharmacotherapy, 40, 248-251.

California study examines TB, HIV, and hepatitis. (1995, December). Correct Care, p. 3-3.

Centers for Disease Control and Prevention . (1990, 9 February). Protection against viral hepatitis. Morbidity and Mortality Weekly Report, 39(RR-2).

Centers for Disease Control and Prevention (1991, 12 July). Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure prone invasive procedures. Morbidity and Mortality Weekly Report, 44(RR-8).

Centers for Disease Control and Prevention . (1993). Epidemiology, prevention, and control of vaccine-preventable diseases. Atlanta, GA: Author.

Centers for Disease Control and Prevention . (1996). Summary of notifiable diseases, United States 1995. Morbidity and Mortality Weekly Report, 44(53), 10-11.

Current concepts in the diagnosis and management of chronic viral hepatitis. (1996). Clinical Courier, 14(16), 1-7.

Glaser, J. B. , & Greifinger, R. B. (1993, 15 January). Correctional health care: A public health opportunity. Annals of Internal Medicine, 188(2): 139-144.

Hoofnagle, Jay H. , & Di Bisceglie, Adrian M. (1997). The treatment of chronic viral hepatitis. The New England Journal of Medicine, 336(5): 347-355.

Lemon, Stanley M. , & Thomas, David L. (1997). Vaccines to prevent viral hepatitis. The New England Journal of Medicine, 336(5): 347-355.

Occupational exposure to blood borne pathogens; final rule (29 CFR Part 1910.1030). Federal Register. December 6, 1991;64175.